Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-008476
Filing Date
2022-08-10
Accepted
2022-08-10 19:31:56
Documents
2
Period of Report
2022-08-08

Document Format Files

Seq Description Document Type Size
1 form4-08102022_040839.html 4  
1 form4-08102022_040839.xml 4 11374
2 ex24-08102022_040839.htm EX-24 7932
  Complete submission text file 0001415889-22-008476.txt   20644
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 221153229